PROCTER & GAMBLE HEALTH | SUN PHARMA | PROCTER & GAMBLE HEALTH/ SUN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 36.8 | 40.2 | 91.6% | View Chart |
P/BV | x | 10.6 | 6.5 | 164.1% | View Chart |
Dividend Yield | % | 2.0 | 0.8 | 262.4% |
PROCTER & GAMBLE HEALTH SUN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SUN PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ SUN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 1,072 | 500.6% | |
Low | Rs | 3,883 | 790 | 491.7% | |
Sales per share (Unadj.) | Rs | 740.7 | 182.9 | 405.0% | |
Earnings per share (Unadj.) | Rs | 138.2 | 35.7 | 387.4% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 46.2 | 335.7% | |
Dividends per share (Unadj.) | Rs | 95.00 | 11.50 | 826.1% | |
Avg Dividend yield | % | 2.1 | 1.2 | 166.3% | |
Book value per share (Unadj.) | Rs | 447.6 | 233.4 | 191.8% | |
Shares outstanding (eoy) | m | 16.60 | 2,399.34 | 0.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 5.1 | 122.7% | |
Avg P/E ratio | x | 33.5 | 26.1 | 128.2% | |
P/CF ratio (eoy) | x | 29.8 | 20.1 | 148.0% | |
Price / Book Value ratio | x | 10.3 | 4.0 | 259.0% | |
Dividend payout | % | 68.7 | 32.2 | 213.2% | |
Avg Mkt Cap | Rs m | 76,761 | 2,233,361 | 3.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 82,960 | 2.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 438,857 | 2.8% | |
Other income | Rs m | 184 | 8,199 | 2.2% | |
Total revenues | Rs m | 12,480 | 447,055 | 2.8% | |
Gross profit | Rs m | 3,247 | 112,900 | 2.9% | |
Depreciation | Rs m | 281 | 25,294 | 1.1% | |
Interest | Rs m | 8 | 1,720 | 0.4% | |
Profit before tax | Rs m | 3,142 | 94,084 | 3.3% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 8,476 | 10.0% | |
Profit after tax | Rs m | 2,295 | 85,608 | 2.7% | |
Gross profit margin | % | 26.4 | 25.7 | 102.6% | |
Effective tax rate | % | 27.0 | 9.0 | 299.3% | |
Net profit margin | % | 18.7 | 19.5 | 95.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 398,619 | 2.9% | |
Current liabilities | Rs m | 6,791 | 199,064 | 3.4% | |
Net working cap to sales | % | 40.0 | 45.5 | 88.0% | |
Current ratio | x | 1.7 | 2.0 | 86.1% | |
Inventory Days | Days | 263 | 147 | 178.7% | |
Debtors Days | Days | 343 | 95 | 361.0% | |
Net fixed assets | Rs m | 10,617 | 376,960 | 2.8% | |
Share capital | Rs m | 166 | 2,399 | 6.9% | |
"Free" reserves | Rs m | 7,265 | 557,555 | 1.3% | |
Net worth | Rs m | 7,431 | 559,954 | 1.3% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 775,794 | 2.9% | |
Interest coverage | x | 409.1 | 55.7 | 734.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.6 | 97.3% | |
Return on assets | % | 10.3 | 11.3 | 91.6% | |
Return on equity | % | 30.9 | 15.3 | 202.0% | |
Return on capital | % | 42.4 | 17.1 | 247.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 154,053 | 1.0% | |
Fx outflow | Rs m | 1,605 | 71,511 | 2.2% | |
Net fx | Rs m | -140 | 82,541 | -0.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 49,593 | 4.8% | |
From Investments | Rs m | -215 | -79,437 | 0.3% | |
From Financial Activity | Rs m | -985 | 23,761 | -4.1% | |
Net Cashflow | Rs m | 1,160 | 1,155 | 100.5% |
Indian Promoters | % | 0.0 | 54.5 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 36.5 | 54.7% | |
FIIs | % | 6.2 | 17.7 | 35.2% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 45.5 | 105.8% | |
Shareholders | 56,778 | 631,392 | 9.0% | ||
Pledged promoter(s) holding | % | 0.0 | 2.1 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | Sun Pharma | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.27% | -0.66% | 0.15% |
1-Month | -0.40% | -7.03% | 0.33% |
1-Year | 1.04% | 56.56% | 54.36% |
3-Year CAGR | -8.94% | 31.80% | 14.52% |
5-Year CAGR | 5.28% | 27.20% | 20.24% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the Sun Pharma share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of Sun Pharma the stake stands at 54.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of Sun Pharma.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
Sun Pharma paid Rs 11.5, and its dividend payout ratio stood at 32.2%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of Sun Pharma.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets Slipped further as the session progressed and ended the day weak.